The Priority Review program is a new initiative launched by the current administration. It was first announced in June of ...
According to a report from Reuters, the President claimed that these drugs would cost $150 out-of-pocket. As of the time of ...
EMD Serono's agreement with the US government aims to expand IVF therapy access for 10 million women, offering significant ...
Peptilogics Founder, CEO, Jonathan Steckbeck, explained that PLG0206 stands apart from current treatments, while the ...
In today’s Pharmaceutical Executive Daily, we explore how antibody-drug conjugate collaborations are moving beyond oncology ...
Veradermics raised $150 million to advance VDPHL01, an oral minoxidil treatment for hair regrowth, through Phase III trials ...
Boehringer Ingelheim and AimedBio collaborate on ADC therapy targeting a protein involved in cancer growth, aiming to enhance ...
In today’s Pharmaceutical Executive Daily, we explore how pharma leaders are rethinking workforce development at the ...
Learn what makes an AI roleplay solution actually move the needle in pharma field team performance. Lead with insight with ...
As the pharmaceutical industry moves beyond rule-based omnichannel marketing, a new era of agentic systems is emerging, in which AI-powered agents collaborate with humans to orchestrate engagement, ...
Biotech funding surges as companies like Pelage, Kardigan, and Kailera secure millions to innovate treatments for hair loss, ...
Bristol Myers Squibb's acquisition of Orbital Therapeutics includes OTX-201, a next-gen CAR T-cell therapy, and a proprietary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback